 | • レポートコード：MRC2302F0209 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、255ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社は、2021年の3,060.10百万ドルであった世界の造影剤市場規模が、2022年に3,349.90百万ドルへ達し、2027年までに年平均9.64%成長し、5,317.63百万ドルへ拡大すると見込んでいます。本書は、造影剤の世界市場を対象に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（バリウム系造影剤、ガドリニウム系造影剤、ヨウ素系造影剤、マイクロバブル造影剤）分析、疾患別（がん、循環器系疾患、消化器系疾患、筋骨格系障害、その他）分析、投与経路別（血管内投与、経口投与、直腸投与）分析、エンドユーザー別（画像診断センター、病院・診療所・外来診療センター）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの項目について調査・分析を行っています。また、市場調査の対象企業には、AMAG Pharmaceuticals, Inc.、Bayer AG、Bracco Imaging s.p.A、Daiichi Sankyo Co. Ltd.、Fuji Pharma Co. Ltd.、GE Healthcare Co., Ltd.、Guerbet、J.B. Chemicals & Pharmaceuticals Ltd.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の造影剤市場規模：種類別 - バリウム系造影剤の市場規模 - ガドリニウム系造影剤の市場規模 - ヨウ素系造影剤の市場規模 - マイクロバブル造影剤の市場規模 ・世界の造影剤市場規模：疾患別 - がんにおける市場規模 - 循環器系疾患における市場規模 - 消化器系疾患における市場規模 - 筋骨格系障害における市場規模 - その他疾患における市場規模 ・世界の造影剤市場規模：投与経路別 - 血管内投与における市場規模 - 経口投与における市場規模 - 直腸投与における市場規模 ・世界の造影剤市場規模：エンドユーザー別 - 画像診断センターにおける市場規模 - 病院・診療所・外来診療センターにおける市場規模 ・世界の造影剤市場規模：地域別 - 南北アメリカの造影剤市場規模 アメリカの造影剤市場規模 カナダの造影剤市場規模 ブラジルの造影剤市場規模 ... - アジア太平洋の造影剤市場規模 日本の造影剤市場規模 中国の造影剤市場規模 インドの造影剤市場規模 韓国の造影剤市場規模 台湾の造影剤市場規模 ... - ヨーロッパ/中東/アフリカの造影剤市場規模 イギリスの造影剤市場規模 ドイツの造影剤市場規模 フランスの造影剤市場規模 ロシアの造影剤市場規模 ... - その他地域の造影剤市場規模 ・競争状況 ・企業情報 |
The Global Contrast Media Market size was estimated at USD 3,060.10 million in 2021 and expected to reach USD 3,349.90 million in 2022, and is projected to grow at a CAGR 9.64% to reach USD 5,317.63 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Contrast Media to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Barium-based Contrast Media, Gadolinium-based Contrast Media, Iodinated Contrast Media, and Microbubble Contrast Media.
Based on Indication, the market was studied across Cancer, Cardiovascular Disorders, Gastrointestinal Disorders, Musculoskeletal Disorders, Nephrological Disorders, and Neurological Disorders.
Based on Route Of Administration, the market was studied across Intravascular Route, Oral Route, and Rectal Route.
Based on Procedure, the market was studied across Magnetic Resonance Imaging (Mri), Ultrasound, and X-ray/Computed Tomography (Ct).
Based on End-user, the market was studied across Diagnostic Imaging Centers and Hospital, Clinics, & Ambulatory Surgery Centers.
Based on Application, the market was studied across Interventional Cardiology, Interventional Radiology, and Radiology.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Contrast Media market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Contrast Media Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Contrast Media Market, including AMAG Pharmaceuticals, Inc., Bayer AG, Bracco Imaging s.p.A, Daiichi Sankyo Co. Ltd., Fuji Pharma Co. Ltd., GE Healthcare Co., Ltd., Guerbet, J.B. Chemicals & Pharmaceuticals Ltd., Jodas Expoim, Lantheus Medical Imaging, Inc., M.Biotech Limited, Medtronic Plc., nanoPET Pharma GmbH, Spago Nanomedical AB, and Taejoon Pharm Co., Ltd..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Contrast Media Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Contrast Media Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Contrast Media Market?
4. What is the competitive strategic window for opportunities in the Global Contrast Media Market?
5. What are the technology trends and regulatory frameworks in the Global Contrast Media Market?
6. What is the market share of the leading vendors in the Global Contrast Media Market?
7. What modes and strategic moves are considered suitable for entering the Global Contrast Media Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in prevalence of long-term diseases coupled with the demand for diagnostic imaging tests
5.1.1.2. Recent approvals of contrast agents and label expansions
5.1.1.3. Growth in number of cancer and Cvds
5.1.2. Restraints
5.1.2.1. Adverse effects associated with contrast media
5.1.3. Opportunities
5.1.3.1. Emerging generic gadolinium-based contrast agents
5.1.3.2. Increasing investment in R&D
5.1.4. Challenges
5.1.4.1. Continuous advancements in imaging technology
5.2. Cumulative Impact of COVID-19
6. Contrast Media Market, by Type
6.1. Introduction
6.2. Barium-based Contrast Media
6.3. Gadolinium-based Contrast Media
6.4. Iodinated Contrast Media
6.5. Microbubble Contrast Media
7. Contrast Media Market, by Indication
7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disorders
7.4. Gastrointestinal Disorders
7.5. Musculoskeletal Disorders
7.6. Nephrological Disorders
7.7. Neurological Disorders
8. Contrast Media Market, by Route Of Administration
8.1. Introduction
8.2. Intravascular Route
8.3. Oral Route
8.4. Rectal Route
9. Contrast Media Market, by Procedure
9.1. Introduction
9.2. Magnetic Resonance Imaging (Mri)
9.3. Ultrasound
9.4. X-ray/Computed Tomography (Ct)
10. Contrast Media Market, by End-user
10.1. Introduction
10.2. Diagnostic Imaging Centers
10.3. Hospital, Clinics, & Ambulatory Surgery Centers
11. Contrast Media Market, by Application
11.1. Introduction
11.2. Interventional Cardiology
11.3. Interventional Radiology
11.4. Radiology
12. Americas Contrast Media Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Contrast Media Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Contrast Media Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. AMAG Pharmaceuticals, Inc.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Bayer AG
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. Bracco Imaging s.p.A
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. Daiichi Sankyo Co. Ltd.
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Fuji Pharma Co. Ltd.
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. GE Healthcare Co., Ltd.
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. Guerbet
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. J.B. Chemicals & Pharmaceuticals Ltd.
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Jodas Expoim
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Lantheus Medical Imaging, Inc.
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. M.Biotech Limited
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Medtronic Plc.
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. nanoPET Pharma GmbH
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. Spago Nanomedical AB
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Taejoon Pharm Co., Ltd.
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing